CF
DCPH

CNA Financial’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

CNA Financial’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,720
Closed -$526K – 211
2021
Q1 		$526K Buy
11,720
+2,690
+30% +$125K 0.16% 156
2020
Q4 		$515K Buy
9,030
+20
+0.2% +$1.19K 0.16% 154
2020
Q3 		$462K Buy
9,010
+1,270
+16% +$62.2K 0.17% 137
2020
Q2 		$462K Buy
+7,740
New +$414K 0.18% 128

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

CNA Financial's DCPH Position: Q2 2021 in Review

CNA Financial sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2021, closing a stake of 11,720 shares — an estimated $526K sold.

CNA Financial first reported a position in DCPH in Q2 2020 and held it in 4 quarters. The position peaked at $526K in Q1 2021. 147 funds tracked by Wall St. Rank hold DCPH as of Q2 2021.

  • CNA Financial reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • CNA Financial sold 11,720 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $526K.
  • CNA Financial first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
  • CNA Financial's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $526K in Q1 2021.
  • 147 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on CNA Financial's 13F filing for Q2 2021, filed 12 Aug 2021.